1. Thoracic radiotherapy and concurrent almonertinib for unresectable stage III EGFR-mutated non-small-cell lung cancer: a phase 2 study
   Lucheng ZHU et al, 2021, BMC Cancer CrossRef
2. Development and Optimization of Osimertinib-loaded Biodegradable Polymeric Nanoparticles Enhance In-vitro Cytotoxicity in Mutant EGFR NSCLC Cell Models and In-vivo Tumor Reduction in H1975 Xenograft Mice Models
   Sanjay Kumar K et al, 2022, AAPS PharmSciTech CrossRef
3. Potential Targets and Mechanisms of Dalbergia odorifera on Treating Lung Adenocarcinoma Explored by Network Pharmacology
   Zhongyv Xiong et al, 2023, International Journal of Pharmacology CrossRef
4. Selenium speciation-dependent cancer radiosensitization by induction of G2/M cell cycle arrest and apoptosis
   Shiqing Nie et al, 2023, Frontiers in Bioengineering and Biotechnology CrossRef